Literature DB >> 33605061

Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.

Dorina Onoya1, Cheryl Hendrickson1, Tembeka Sineke1, Mhairi Maskew1, Lawrence Long1,2, Jacob Bor1,2, Matthew P Fox1,2,3.   

Abstract

INTRODUCTION: Policies for Universal Test & Treat (UTT) and same-day initiation (SDI) of antiretroviral therapy (ART) were instituted in South Africa in September 2016 and 2017 respectively. However, there is limited evidence on whether these changes have improved patient retention after HIV diagnosis.
METHODS: We enrolled three cohorts of newly diagnosed HIV-infected adults from two primary health clinics in Johannesburg from April to November 2015 (Pre-UTT, N = 144), May-September 2017 (UTT, N = 178) and October-December 2017 (SDI, N = 88). A baseline survey was administered immediately after HIV diagnosis after which follow-up using clinical records (paper charts, electronic health records and laboratory data) ensued for 12 months. The primary outcome was patient loss to follow-up (being >90 days late for the last scheduled appointment) at 12 months post-HIV diagnosis. We modelled attrition across HIV policy periods with Cox proportional hazard regression.
RESULTS: Overall, 410 of 580 screened HIV-positive patients were enrolled. Overall, attrition at 12 months was 30% lower in the UTT guideline period (38.2%) compared to pre-UTT (47.2%, aHR 0.7, 95% CI: 0.5 to 1.0). However, the total attrition was similar between the SDI (47.7%) and pre-UTT cohorts (aHR 1.0, 95% CI: 0.7 to 1.5). Older age at HIV diagnosis (aHR 0.5 for ≥40 vs. 25 to 29 years, 95% CI: 0.3 to 0.8) and being in a non-marital relationship (aHR 0.5 vs. being single, 95% CI: 0.3 to 0.8) protected against LTFU at 12 months, whereas LTFU rates increased with longer travel time to the diagnosing clinic (aHR 1.8 for ≥30 minutes vs. ≤15 minutes, 95% CI: 1.1 to 3.1). In analyses adjusted for the time-varying ART initiation status, compared to the pre-ART period of care, the hazard of on-ART LTFU was 90% higher among participants diagnosed under the SDI policy compared to pre-UTT (aHR 1.9, 95% CI: 1.1 to 2.9).
CONCLUSIONS: Overall, nearly two-fifths of HIV positive patients are likely to disengage from care by 12 months after HIV diagnosis under the new SDI policy. Furthermore, the increase in on-ART patient attrition after the introduction of the SDI policy is cause for concern. Further research is needed to determine the best way for rapidly initiating patients on ART and also reducing long-term attrition from care.
© 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Entities:  

Keywords:  ART access; ART adherence; HIV; Universal Test and Treat; attrition from HIV care; same-day initiation of ART

Year:  2021        PMID: 33605061      PMCID: PMC7893145          DOI: 10.1002/jia2.25652

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


  34 in total

1.  A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among More Than 300,000 Patients Enrolled During 2004-2013.

Authors:  Andrew F Auld; Ray W Shiraishi; Aleny Couto; Francisco Mbofana; Kathryn Colborn; Charity Alfredo; Tedd V Ellerbrock; Carla Xavier; Kebba Jobarteh
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

2.  Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.

Authors:  Sydney Rosen; Mhairi Maskew; Matthew P Fox; Cynthia Nyoni; Constance Mongwenyana; Given Malete; Ian Sanne; Dorah Bokaba; Celeste Sauls; Julia Rohr; Lawrence Long
Journal:  PLoS Med       Date:  2016-05-10       Impact factor: 11.069

3.  Community Cultural Norms, Stigma and Disclosure to Sexual Partners among Women Living with HIV in Thailand, Brazil and Zambia (HPTN 063).

Authors:  Bisola O Ojikutu; Subash Pathak; Kriengkrai Srithanaviboonchai; Mohammed Limbada; Ruth Friedman; Shuying Li; Matthew J Mimiaga; Kenneth H Mayer; Steven A Safren
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

4.  Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.

Authors:  Dorina Onoya; Cornelius Nattey; Eric Budgell; Liudmyla van den Berg; Mhairi Maskew; Denise Evans; Kamban Hirasen; Lawrence C Long; Matthew P Fox
Journal:  AIDS Patient Care STDS       Date:  2017-04-26       Impact factor: 5.078

Review 5.  The STROBE guidelines.

Authors:  Sarah Cuschieri
Journal:  Saudi J Anaesth       Date:  2019-04

6.  Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).

Authors:  Andréa Gosset; Camelia Protopopescu; Joseph Larmarange; Joanna Orne-Gliemann; Nuala McGrath; Deenan Pillay; François Dabis; Collins Iwuji; Sylvie Boyer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-01       Impact factor: 3.731

Review 7.  Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.

Authors:  Katharina Kranzer; Darshini Govindasamy; Nathan Ford; Victoria Johnston; Stephen D Lawn
Journal:  J Int AIDS Soc       Date:  2012-11-19       Impact factor: 5.396

8.  Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.

Authors:  Portia C Mutevedzi; Richard J Lessells; Marie-Louise Newell
Journal:  Trop Med Int Health       Date:  2013-06-03       Impact factor: 2.622

9.  Benefits and risks of rapid initiation of antiretroviral therapy.

Authors:  Nathan Ford; Chantal Migone; Alexandra Calmy; Bernhard Kerschberger; Steve Kanters; Sabin Nsanzimana; Edward J Mills; Graeme Meintjes; Marco Vitoria; Meg Doherty; Zara Shubber
Journal:  AIDS       Date:  2018-01-02       Impact factor: 4.177

10.  Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.

Authors:  Collins Iwuji; Nuala McGrath; Alexandra Calmy; Francois Dabis; Deenan Pillay; Marie-Louise Newell; Kathy Baisley; Kholoud Porter
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

View more
  2 in total

1.  Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three-arm cluster randomized controlled trial.

Authors:  Wayne T Steward; Emily Agnew; Julia de Kadt; Mary Jane Ratlhagana; Jeri Sumitani; Hailey J Gilmore; Jessica Grignon; Starley B Shade; John Tumbo; Scott Barnhart; Sheri A Lippman
Journal:  J Int AIDS Soc       Date:  2021-08       Impact factor: 6.707

2.  Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.

Authors:  Samuel Muhula; John Gachohi; Yeri Kombe; Simon Karanja
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.